Graduate Faculty Directory
John Gilly
Department of Pharmaceutical and Healthcare Business
Education
- BS (Indiana University of Pennsylvania)
- MS (University of Scranton)
- Ph.D (Lehigh University)
Faculty Appointments
Adjunct Associate Professor of Pharmaceutical Business
Professional Information
President
Premier Research Group plc
Synopsis
Mr. Gilly is responsible for the day-to-day functional operations of Premier Research Group. Prior to joining Premier in October 2002, Dr. Gilly was Vice President, Manufacturing Division for BioReliance Corporation where he was responsible for the management of the contract manufacturing business. Prior to joining BioReliance in January 1999, he held the position of Vice President, Biopharmaceutical Operations for ImClone Systems Incorporated responsible for development, manufacturing, quality operations and regulatory affairs at the Somerville, NJ facility. Previously, Dr. Gilly was employed by Connaught Laboratories, Inc., a worldwide leader in the supply of pediatric and adult vaccines, working in various research and product development capacities for twelve years. His last position was Director of Product Development directing laboratory activities for new product development at the U.S. subsidiary of Pasteur Merieux Connaught (now Sanofi Pasteur).
He is currently an advisor to the National Cancer Institute BioPharmaceutical Development Program at the NCI Cancer Center in Frederick, MD.
Publications & Presentations
- V. Anderson, M. Cooper, E. O'Chei, J. Gilly, J. Falcey and H. Waksal, "Dose Dependent Pharmacokinetics of a Climerized Monoclonal Antibody (C225) Against EGFR", Proc. Am. Assoc. Cancer Res., Vol 39: 3561, 1998.
- J. Gilly and J. Sands, "Electrophoretic Karyotype of Trichoderma reesei", Biotechnology Letters, Vol 13, pp. 477-482, July 1991.
- J. Gilly, "Getting the Product into Production", Proceedings, 1989 International Congree on Technology and Technology Exchange (ICTTE), New York, NY, pp. 213-215, June 20, 1989.
- J. Gilly, "Data Retrieval and Analysis for Radioimmunoassays", Computer Programs in Biomedicine, Vol. 19, pp. 75-79, 1984.
- J. Gilly, "Preclinical Considerations for Gene Therapy Product Safety Evaluation", Eighth International Conference on Gene Therapy of Cancer, December 1999, San Diego, CA.
- J. Gilly, "Product Testing for sterility and Bioburden", Microbiological Monitoring and Control, October 1999, Philadelphia, PA.
- J. Gilly, "Developing Monclonal Antibodies as Growth Factor Receptor Antagonists", The 3rd Annual Waterside Conference, April 1998, Norfolk, VA.
- J. Gilly, "Upgrading Pilot Plants for FDA Approval", Biotechnology Council of New Jersey Manufacturing Forum, January 1996, Bridgewater, NJ.
- J. Gilly, "Managing Uncertainity: Strategic Manufacturing Planning", 4th Annual Meeting, New York Biotechnology Association, October 1994, New York, NY.
